Twist Bioscience to Present at Baird Global Healthcare Conference 2024
Twist Bioscience (NASDAQ: TWST), a leading synthetic DNA provider, has announced its participation in the Baird Global Healthcare Conference 2024. Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present on Tuesday, September 10 at 2:35 p.m. Eastern Time in New York City.
The presentation will be webcast live and accessible through the company's investor relations website. A replay will be available for 30 days following the event. This conference appearance provides an opportunity for Twist Bioscience to showcase its silicon-based DNA synthesis platform and engage with healthcare industry professionals and investors.
Twist Bioscience (NASDAQ: TWST), un fornitore leader di DNA sintetico, ha annunciato la sua partecipazione alla Baird Global Healthcare Conference 2024. Emily Leproust, Ph.D., CEO e co-fondatrice di Twist Bioscience, presenterà martedì 10 settembre alle 14:35 ora orientale a New York City.
La presentazione sarà trasmessa in diretta streaming e accessibile tramite il sito web delle relazioni con gli investitori dell'azienda. Una registrazione sarà disponibile per 30 giorni dopo l'evento. Questa partecipazione alla conferenza offre a Twist Bioscience l'opportunità di mostrare la sua piattaforma di sintesi del DNA basata sul silicio e di interagire con professionisti e investitori del settore sanitario.
Twist Bioscience (NASDAQ: TWST), un proveedor líder de ADN sintético, ha anunciado su participación en la Baird Global Healthcare Conference 2024. Emily Leproust, Ph.D., CEO y cofundadora de Twist Bioscience, presentará el martes, 10 de septiembre a las 2:35 p.m. hora del Este en Nueva York.
La presentación se transmitirá en vivo y será accesible a través del sitio web de relaciones con los inversores de la empresa. Una reproducción estará disponible por 30 días después del evento. Esta aparición en la conferencia brinda una oportunidad para que Twist Bioscience exhiba su plataforma de síntesis de ADN basada en silicio y se relacione con profesionales e inversores de la industria de la salud.
트위스트 바이오사이언스 (NASDAQ: TWST), 선도적인 합성 DNA 공급업체,가 베어드 글로벌 헬스케어 컨퍼런스 2024에 참여한다고 발표했습니다. 에밀리 레프러스트 박사, 트위스트 바이오사이언스의 CEO이자 공동 창립자는 9월 10일 화요일 오후 2시 35분 동부 표준시에 뉴욕에서 발표를 진행할 예정입니다.
발표는 실시간 웹캐스트로 진행되며 회사의 투자자 관계 웹사이트를 통해 접근할 수 있습니다. 이벤트 후 30일 동안 다시 시청할 수 있는 재생기능이 제공됩니다. 이번 컨퍼런스 참여는 트위스트 바이오사이언스가 실리콘 기반의 DNA 합성 플랫폼을 선보이고 헬스케어 산업 전문가 및 투자자들과 소통할 수 있는 기회를 제공합니다.
Twist Bioscience (NASDAQ: TWST), un fournisseur de premier plan d'ADN synthétique, a annoncé sa participation à la Baird Global Healthcare Conference 2024. Emily Leproust, Ph.D., PDG et co-fondatrice de Twist Bioscience, fera une présentation le mardi 10 septembre à 14h35, heure de l'Est à New York.
La présentation sera diffusée en direct et accessible via le site web des relations investisseurs de l'entreprise. Un enregistrement sera disponible pendant 30 jours après l'événement. Cette participation à la conférence offre à Twist Bioscience l'occasion de présenter sa plateforme de synthèse d'ADN à base de silicium et d'interagir avec des professionnels et des investisseurs du secteur de la santé.
Twist Bioscience (NASDAQ: TWST), ein führender Anbieter von synthetischer DNA, hat seine Teilnahme an der Baird Global Healthcare Conference 2024 bekannt gegeben. Emily Leproust, Ph.D., CEO und Mitgründerin von Twist Bioscience, wird am Dienstag, den 10. September um 14:35 Uhr Eastern Time in New York City präsentieren.
Die Präsentation wird live übertragen und über die Investor Relations-Website des Unternehmens zugänglich sein. Eine Wiederholung wird für 30 Tage nach der Veranstaltung verfügbar sein. Diese Konferenzteilnahme bietet Twist Bioscience die Möglichkeit, ihre silikonbasierte DNA-Syntheseplattform vorzustellen und mit Fachleuten und Investoren der Gesundheitsbranche in Kontakt zu treten.
- None.
- None.
The presentation will be webcast live and can be accessed by visiting the “Investor Calendar” page of the investor relations section of the company's website here. A replay of the presentation will be archived for a period of 30 days following the conclusion of the live events.
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
Follow us on LinkedIn | X | YouTube | Instagram
View source version on businesswire.com: https://www.businesswire.com/news/home/20240827998564/en/
For Investors:
Angela Bitting
SVP, Corporate Affairs
925-202-6211
abitting@twistbioscience.com
For Media:
Amanda Houlihan
Communications Manager
774-265-5334
ahoulihan@twistbioscience.com
Source: Twist Bioscience Corporation
FAQ
When is Twist Bioscience (TWST) presenting at the Baird Global Healthcare Conference 2024?
Who will be representing Twist Bioscience (TWST) at the Baird Global Healthcare Conference 2024?
How can I access Twist Bioscience's (TWST) presentation at the Baird Global Healthcare Conference 2024?
How long will the replay of Twist Bioscience's (TWST) presentation be available?
